GGrantIndex
← Leaderboards

Minoli A Perera

University Of Chicago

$7,566,589
Attributed
$11,678,607
Total exposure
11
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.2M · FY200924
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$21,205,773 · 12

By mechanism

U54$17,005,272 · 7
R01$2,723,569 · 2
R21$876,267 · 2
K23$600,665 · 1

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “African American

Research focus

African AmericanPharmacogeneticsTranslationsPharmacogenomicsAmericanPharmaceutical PreparationsGenomicsVariantGenotypeCardiovascular SystemPhenotypeBaseEuropeanGenesPrecision MedicineResponsePhysiciansAffectEvaluationCommunitiesClinical CareResearch PersonnelResourcesArea

Grant awards (45)

Social, Genomic, and Epigenomic Drivers of Clopidogrel Response in Puerto Ricans$745,930
R01 · FY2024 · HG · contact PI
Use of a Machine Learning Approach to Impute Gene Expression in African Americans$200,000
R21 · FY2022 · HG · contact PI
Use of a Machine Learning Approach to Impute Gene Expression in African Americans$239,250
R21 · FY2021 · HG · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$1,995,641
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$653,336
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$626,351
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$332,861
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$184,034
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$130,256
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$68,803
U54 · FY2020 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$1,768,551
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$579,026
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$556,130
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$307,885
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$153,940
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$107,929
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$63,641
U54 · FY2019 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$1,833,557
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$600,295
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$576,287
U54 · FY2018 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$395,000
R01 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$315,752
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$162,048
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$113,907
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$65,268
U54 · FY2018 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$1,880,357
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$615,513
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$587,801
U54 · FY2017 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$390,548
R01 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$284,668
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$193,952
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$139,581
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$58,842
U54 · FY2017 · MD · contact PI
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation$2,049,060
U54 · FY2016 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$334,159
R01 · FY2016 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$65,173
R01 · FY2016 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$399,296
R01 · FY2015 · MD · contact PI
Health disparity in pharmacogenomics: African American SNPs and drug metabolism$393,463
R01 · FY2014 · MD · contact PI
The implementation of a pharmacogenomics-based algorithm for warfarin dosing$120,339
K23 · FY2013 · HL · contact PI
Comprehensive studies of novel SNPs affecting warfarin dose in African Americans$195,386
R21 · FY2012 · HL · contact PI
The implementation of a pharmacogenomics-based algorithm for warfarin dosing$120,339
K23 · FY2012 · HL · contact PI
Comprehensive studies of novel SNPs affecting warfarin dose in African Americans$241,631
R21 · FY2011 · HL · contact PI
The implementation of a pharmacogenomics-based algorithm for warfarin dosing$120,415
K23 · FY2011 · HL · contact PI
The implementation of a pharmacogenomics-based algorithm for warfarin dosing$120,339
K23 · FY2010 · HL · contact PI
The implementation of a pharmacogenomics-based algorithm for warfarin dosing$119,233
K23 · FY2009 · HL · contact PI